U.K. researchers announced Tuesday they are studying if vitamin A nasal drops could treat loss or altered sense of smell in patients who suffered from COVID-19.
Scientists at the University of East Anglia (UEA) and James Paget University Hospital will begin a 12-week trial providing volunteers with either vitamin A or placebo nasal drops, according to the study. The treatment will look to repair tissue in the nose that was damaged by the virus.
Vitamin-A treatment trial for Covid loss of smell https://t.co/TvoHsW90MV
— BBC News (World) (@BBCWorld) September 29, 2021
“The huge rise in smell loss caused by COVID-19 has created an unprecedented worldwide demand for treatment,” Carl Philpott, professor at UEA’s Norwich Medical School and James Paget University Hospitals National Health Service Trust, said. (RELATED: COVID’s Long-Term Effects Can Cause Memory Lapses, Hair Loss Even In Mild Cases, According To Early Studies)
Philpott highlights the various impacts of smell loss, including depression, anxiety, and isolation, along with a reduction in appetite and the potential to consume spoiled or dangerous foods.
Participants will be asked to smell specific smells like roses and rotten eggs while also undergoing brain scans, Philpott explained. The scans will tell if the nerves used for smelling and detecting odors have been repaired after being damaged by the virus.
Roughly 1 in 10 COVID-19 patients who lost their sense of smell did not fully recover within four weeks, and Philpott believes a key problem is “the lack of proven effective treatments.”
A previous study performed in Germany found that those treated with vitamin A recovered almost twice as much as those who did not use the treatment, according to Philpott.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.